Decipher Labs Ltd

Decipher Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Decipher Labs Ltd

₹ 5.95 -1.65%
24 Jul - close price
combatdrugs.in BSE: 524752
About

Incorporated in 1986, Decipher Labs Ltd deals in pharma and consultancy business.[1]

Key Points

Business Overview:[1]
DCL is in the business of:
a) Pharma:
Manufacturing and trading of Pharmaceutical products
b) Consultancy:
It also provides consultancy services

Website BSE
  • Market Cap ₹ 6.01 Cr.
  • Current Price ₹ 5.95
  • High / Low ₹ 11.7 / 5.00
  • Stock P/E
  • Book Value ₹ 8.16
  • Dividend Yield 0.00 %
  • ROCE -2.75 %
  • ROE -2.99 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.73 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 3.07% over past five years.
  • Promoter holding is low: 16.4%
  • Company has a low return on equity of -2.58% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
0.13 0.00 0.00 0.17 3.36 0.38 0.08 0.16 0.23 0.85 0.09 0.13 0.07
0.46 0.11 0.10 0.07 3.24 0.50 0.15 0.25 0.39 0.79 0.20 0.13 0.24
Operating Profit -0.33 -0.11 -0.10 0.10 0.12 -0.12 -0.07 -0.09 -0.16 0.06 -0.11 0.00 -0.17
OPM % -253.85% 58.82% 3.57% -31.58% -87.50% -56.25% -69.57% 7.06% -122.22% 0.00% -242.86%
0.00 0.01 0.01 0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.34 -0.10 -0.09 0.10 0.13 -0.12 -0.05 -0.09 -0.16 0.06 -0.11 0.00 -0.17
Tax % 8.82% 20.00% -22.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.37 -0.12 -0.07 0.09 0.12 -0.13 -0.06 -0.09 -0.17 0.06 -0.12 -0.01 -0.17
EPS in Rs -0.37 -0.12 -0.07 0.09 0.12 -0.13 -0.06 -0.09 -0.17 0.06 -0.12 -0.01 -0.17
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.10 0.22 0.38 1.02 6.78 1.42 0.98 0.99 0.81 3.53 0.85 1.14
0.29 0.80 0.56 0.95 6.41 1.26 0.96 0.63 1.11 3.51 1.29 1.36
Operating Profit -0.19 -0.58 -0.18 0.07 0.37 0.16 0.02 0.36 -0.30 0.02 -0.44 -0.22
OPM % -190.00% -263.64% -47.37% 6.86% 5.46% 11.27% 2.04% 36.36% -37.04% 0.57% -51.76% -19.30%
-3.26 -0.61 0.00 0.11 0.01 0.01 0.14 0.05 -2.28 0.02 0.02 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00
Depreciation 0.23 0.09 0.00 0.00 0.00 0.00 0.04 0.05 0.06 0.01 0.02 0.02
Profit before tax -3.68 -1.28 -0.18 0.18 0.38 0.17 0.10 0.36 -2.64 0.03 -0.44 -0.24
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.76% 0.00% 0.00% 4.17%
-3.68 -1.28 -0.18 0.18 0.38 0.17 0.10 0.36 -2.62 0.02 -0.44 -0.25
EPS in Rs -4.60 -1.60 -0.22 0.22 0.48 0.17 0.10 0.36 -2.59 0.02 -0.44 -0.25
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 18%
5 Years: 3%
3 Years: 12%
TTM: 34%
Compounded Profit Growth
10 Years: 5%
5 Years: %
3 Years: 6%
TTM: 43%
Stock Price CAGR
10 Years: 4%
5 Years: -30%
3 Years: -28%
1 Year: -46%
Return on Equity
10 Years: 0%
5 Years: -1%
3 Years: -3%
Last Year: -3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 8.00 8.00 8.00 8.00 8.00 10.10 10.10 10.10 10.10 10.10 10.10 10.10
Reserves -4.60 -5.88 -6.06 -5.88 -5.50 0.97 1.06 1.42 -1.20 -1.17 -1.61 -1.86
0.00 0.00 0.05 0.13 0.14 0.23 0.14 0.00 0.00 0.00 0.25 0.50
0.45 0.49 0.59 0.71 3.20 0.35 0.10 0.08 0.09 3.83 0.44 0.26
Total Liabilities 3.85 2.61 2.58 2.96 5.84 11.65 11.40 11.60 8.99 12.76 9.18 9.00
0.86 0.00 0.00 0.00 0.01 0.11 0.26 0.33 0.12 0.10 0.14 0.12
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.05 8.41 8.41 8.66 8.66 8.66 8.66 8.66
2.99 2.61 2.58 2.96 5.78 3.13 2.73 2.61 0.21 4.00 0.38 0.22
Total Assets 3.85 2.61 2.58 2.96 5.84 11.65 11.40 11.60 8.99 12.76 9.18 9.00

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
0.10 -0.25 -0.02 -0.10 0.04 -0.01 0.27 0.55 -0.08 -0.03 0.07 -0.29
0.00 0.16 0.00 0.00 -0.05 -0.07 -0.19 -0.38 0.09 0.00 -0.05 0.00
0.00 0.00 0.05 0.09 0.01 0.09 -0.09 -0.14 0.00 0.00 0.00 0.26
Net Cash Flow 0.10 -0.09 0.03 -0.01 -0.01 0.01 -0.01 0.03 0.01 -0.03 0.03 -0.03
Free Cash Flow 0.10 -0.09 -0.02 -0.10 0.03 -0.12 0.08 0.42 0.01 -0.03 0.02 -0.29
CFO/OP -53% 43% 11% -143% 11% -6% 1,350% 153% 27% -150% -16% 132%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 292.00 116.14 134.47 211.13 163.66 43.70 152.70 81.11 58.58 408.43 98.76 9.61
Inventory Days 2,027.78 696.82 98.27 91.25 19.70 188.39 34.76 91.25 0.00 0.00 0.00 0.00
Days Payable 1,013.89 1,294.09 645.77 511.00 192.66 135.40 0.00 0.00
Cash Conversion Cycle 1,305.89 -481.14 -413.03 -208.62 -9.30 96.68 187.47 172.36 58.58 408.43 98.76 9.61
Working Capital Days 839.50 -165.91 -259.34 751.47 130.28 647.75 923.67 910.66 13.52 11.37 -180.35 -35.22
ROCE % -6.27% -23.91% -8.76% 8.49% 15.54% 2.44% 1.06% 3.16% -3.23% 0.34% -4.98% -2.75%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Pharma segment customer concentration (top single customer as % of Pharma segment revenue)
%

Log in to view insights

Please log in to see hidden values.

Login
Pharma segment share of consolidated revenue
%
Number of countries of operation
count
Number of subsidiaries
count
Foreign exchange earnings (inflows)
USD
Number of permanent employees on rolls (standalone)
count
India share of consolidated revenue (by customer location)
%
IT Consultancy segment customer concentration (top single customer as % of IT segment revenue)
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43% 16.43%
83.57% 83.57% 83.58% 83.57% 83.57% 83.58% 83.56% 83.57% 83.57% 83.58% 83.59% 83.57%
No. of Shareholders 35,72834,51133,37132,83331,83831,48231,18230,51230,17429,82529,59629,368

Documents

Announcements

Annual reports